PMID: 10840192Jun 7, 2000Paper

Improving drug solubility for oral delivery using solid dispersions

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
C Leuner, J Dressman

Abstract

The solubility behaviour of drugs remains one of the most challenging aspects in formulation development. With the advent of combinatorial chemistry and high throughput screening, the number of poorly water soluble compounds has dramatically increased. Although solid solutions have tremendous potential for improving drug solubility, 40 years of research have resulted in only a few marketed products using this approach. With the introduction of new manufacturing technologies such as hot melt extrusion, it should be possible to overcome problems in scale-up and for this reason solid solutions are enjoying a renaissance. This article begins with an overview of the historical background and definitions of the various systems including eutectic mixtures, solid dispersions and solid solutions. The remainder of the article is devoted to the production, the different carriers and the methods used for the characterization of solid dispersions.

References

Sep 1, 1976·The Journal of Pharmacy and Pharmacology·O I CorriganM J Whelan
Feb 1, 1989·The Journal of Pharmacy and Pharmacology·C Doherty, P York
Jul 1, 1985·The Journal of Pharmacy and Pharmacology·J L Dubois, J L Ford
Oct 1, 1969·The Journal of Pharmacy and Pharmacology·T R Bates
Sep 1, 1971·Journal of Pharmaceutical Sciences·W L Chiou, S Riegelman
Dec 1, 1969·Journal of Pharmaceutical Sciences·W L Chiou, S Riegelman
May 1, 1969·Journal of Pharmaceutical Sciences·A P SimonelliW I Higuchi
Nov 1, 1966·Journal of Pharmaceutical Sciences·M Mayersohn, M Gibaldi
Oct 1, 1994·European Journal of Drug Metabolism and Pharmacokinetics·M J AriasA M Rabasco
Apr 1, 1994·Journal of Pharmaceutical Sciences·N KondoY Ogawa
Oct 1, 1996·Journal of Pharmaceutical Sciences·T Loftsson, M E Brewster
Jan 1, 1997·Journal of Pharmaceutical Sciences·B C Hancock, G Zografi
Apr 27, 1999·The Journal of Pharmacy and Pharmacology·N KohriK Miyazaki
Jun 17, 1999·International Journal of Pharmaceutics·V TantishaiyakulS Ingkatawornwong
Feb 1, 1964·Journal of Pharmaceutical Sciences·J L KANIG

❮ Previous
Next ❯

Citations

Mar 24, 2005·Pharmaceutical Research·Marc Galop
Mar 24, 2007·Pharmaceutical Research·Feng QianRonald L Smith
Mar 27, 2007·Pharmaceutical Research·Harvinder S Gill, Mark R Prausnitz
Feb 13, 2010·Pharmaceutical Research·David E AlonzoLynne S Taylor
Sep 23, 2009·Pharmaceutical Research·Alfred C F RumondorLynne S Taylor
Feb 3, 2012·Pharmaceutical Research·Bernard Van Eerdenbrugh, Lynne S Taylor
Mar 17, 2012·Pharmaceutical Research·Stéphanie GrecoAudrey Segalini
Aug 28, 2012·Pharmaceutical Research·Blair Kathryn BrettmannBernhardt L Trout
May 11, 2012·Frontiers of Medicine·Liyuan ChenXiguang Chen
May 28, 2009·Archives of Pharmacal Research·Young-Joon ParkHan-Gon Choi
Aug 31, 2010·Archives of Pharmacal Research·Young Joon ParkHyo-Kyung Han
Apr 7, 2011·Archives of Pharmacal Research·Raja Hemanth Kumar PotluriPrabhakar Reddy Veerareddy
Jul 5, 2011·Archives of Pharmacal Research·Xia ZhaoJianxia Mo
Dec 6, 2011·Archives of Pharmacal Research·Ying ChenHong Liu
Aug 13, 2011·European Journal of Drug Metabolism and Pharmacokinetics·Evren GundogduErcument Karasulu
Mar 5, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·D J van DroogeH W Frijlink
May 25, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ilse WeutsGuy Van den Mooter
May 17, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ilse WeutsGuy Van den Mooter
May 28, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Satomi OnoueShizuo Yamada
Aug 3, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Toshiyuki Niwa, Kazumi Danjo
May 8, 2004·International Journal of Pharmaceutics·Jiahui HuRobert O Williams
Mar 17, 2004·International Journal of Pharmaceutics·S Sethia, E Squillante
Mar 22, 2005·International Journal of Pharmaceutics·Makiko FujiiYoshiteru Watanabe
May 9, 2013·International Journal of Pharmaceutics·S SotthiviratD Zhang
Apr 27, 2013·International Journal of Pharmaceutics·Justin M KeenRobert O Williams
May 18, 2013·International Journal of Pharmaceutics·Sen Xu, Wei-Guo Dai
Jun 4, 2013·International Journal of Pharmaceutics·Hakon H SigurdssonClaus-Michael Lehr
Jun 8, 2013·International Journal of Pharmaceutics·Asuka InadaYoshinari Baba
Jun 26, 2013·International Journal of Pharmaceutics·Waleed FaisalBrendan T Griffin
Jul 23, 2013·International Journal of Pharmaceutics·Paul T WhitesideClive J Roberts
Jul 24, 2013·International Journal of Pharmaceutics·Phuong Ha-Lien TranBeom-Jin Lee
Sep 3, 2013·International Journal of Pharmaceutics·Ziyaur Rahman, Mansoor A Khan
Sep 10, 2013·International Journal of Pharmaceutics·Petra A PriemelClare J Strachan
Nov 26, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tooru OoyaKinam Park

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.